Polyunsaturated fatty acid intake and prevalence of eczema and rhinoconjunctivitis in Japanese children: the Ryukyus Child Health Study.BMC Public Health. BMC Public Health. 2011 May 21;11:358. Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. miyake-y@fukuoka-u.ac.jp BACKGROUND: The recent increase in the prevalence of allergic disorders might be a consequence of increased intake of n-6 polyunsaturated fatty acids (PUFAs) and reduced intake of n-3 PUFAs. The current cross-sectional study examined the association between intake levels and the prevalence of eczema and rhinoconjunctivitis in Japanese children.METHODS: Subjects were 23,388 schoolchildren aged 6-15 years residing in Okinawa. The presence of eczema and/or rhinoconjunctivitis was determined according to the criteria of the International Study of Asthma and Allergies in Childhood. A brief diet history questionnaire for children and adolescents was administered to acquire information on dietary factors. Adjustment was made for age, sex, residential municipality, number of siblings, smoking in the household, body mass index, paternal and maternal history of allergic diseases, and paternal and maternal educational level.RESULTS: The prevalences of eczema and rhinoconjunctivitis in the previous 12 months were 7.0% and 8.0%, respectively. Consumption of PUFAs, n-3 PUFAs, α-linolenic acid, n-6 PUFAs, and linoleic acid was positively associated with the prevalence of eczema: the adjusted odds ratios (ORs) between extreme quintiles (95% confidence intervals [CIs], P for trend) were 1.26 (1.07-1.48, 0.04), 1.31 (1.11-1.54, 0.009), 1.31 (1.12-1.55, 0.003), 1.26 (1.07-1.48, 0.01), and 1.27 (1.08-1.49, 0.01), respectively. Arachidonic acid intake was independently inversely related to eczema: the adjusted OR between extreme quintiles was 0.81 (0.69-0.95, 0.0008). Eczema was not associated with eicosapentaenoic or docosahexaenoic acid intake, or with the ratio of n-3 to n-6 PUFA intake. Only arachidonic acid intake was statistically significantly related to the prevalence of rhinoconjunctivitis, showing a clear inverse linear trend: the adjusted OR between extreme quintiles was 0.86 (0.74-0.997, 0.03). CONCLUSIONS: Consumption of n-3 and n-6 PUFAs, especially α-linolenic acid and linoleic acid, may be positively associated with eczema. Arachidonic acid intake may be inversely related to eczema and rhinoconjunctivitis.
Wednesday, February 1, 2012
孕婦(21周後) 吃魚油 預防寶寶濕疹??
Fish Oil Beneficial for Mums and Babies Submitted by Annabel Tautou on Wed, 02/01/2012 It has been found that if expecting mums take fish oil then they can prevent their babies from being affected with eczema. The revelation has been made by scientists of the Adelaide University. The scientists have recommended that expecting mums should take Omega 3 fatty acids. The scientists conducted a small study before drawing the conclusion. For the study, the researchers recruited 706 pregnant mums. These women had family history of the allergies. During the study, half of the women were provided with the fish oil three times a day, beginning from the 21st week of pregnancy to the final delivery. The other half were provided with vegetable oils only. It was found that consumption of fish oil supplements reduce one-third of chances of a child towards developing eczema. In 2009, a similar study was conducted in Sweden. The findings of the study also affirmed that the fish oil supplements reduce the chances of a mother passing allergy to their children. Catrin Furuhjelm, of Linkoping University in Sweden, said, "In Sweden, the recommendation is for all mothers to eat fish three times a week during pregnancy, and future studies will tell us if there's a reason to increase this dose". It has been found that the consumption of fish would is beneficial for mothers, though it is yet to be gauged whether or not it could help in preventing the transmission of asthma. Therefore, further studies on the benefits of fish oil consumption have been called for. The consumption of fish oil is no doubt beneficial, it is necessary for women to know that the fish should not be consumed in large quantity. It has been informed that more than four portions of fish a week can put the life of the fetus at risk.
生醫分子檢測產業發展聯盟
『生醫分子檢測產業發展聯盟』成立大會暨『分子檢測發展臺灣現狀與未來』研討會February 1st, 2012近年來,「個人化醫療保健」已成為國際醫療與健康產業的發展趨勢,相關之各類疾病檢驗、標靶治療、用藥相關基因資訊以及基因標記等分子檢測市場逐年明顯成長,分子檢測也成為全球IVD發展最快的領域。在台灣,我們也已有不少業界和研究單位陸續在個人化醫療分子檢測領域裡,投入相當多努力,也建立了良好的基礎及能量。國內業者因此也發起籌組了『生醫分子檢測產業發展聯盟』(簡稱:分子檢測聯盟),希望能藉此:(1)分享經驗資訊,共同尋求資源及協助;(2)結合各單位不同專長及優勢,提高產品及服務之市場競爭力;(3)共同拓展兩岸及國際市場。但未來,我們如何進一步成長茁壯?如何才能持續創造新技術與新產品?如何進一步拓展國際市場,在產業社群中建立出不可或缺的地位?活動時間:民國101年 2月9日 (星期四) PM 13:40 ~ 17:00活動地點:南港軟體園區生技育成中心 大會議室
地址: 台北市南港區園區街3號17樓 報名方式:(由於座位僅限三十名,敬請提前報名,謝謝!)請Email或傳真報名表至報名窗口: 世基生物醫學 蘇芳儀小姐E-mail:sophie.su@pharmigene.com TEL:(02)2695-9800 分機:228 FAX:(02) 2695-7707 5883 報名截止日: 民國101年2月7日(星期二)
活動議程:
| 時間 | 主題 | 主講人 | |||
| 13:40~14:00 | 報到 |
| |||
| 14:00~14:20 | 臺灣生技優勢的新興領域–『分子檢測』 | 李鍾熙董事長 生技中心 | |||
| 14:20~14:40 | 臺灣生技公司在分子檢測全球與大陸市場的定位與發展策略 | 張世忠董事長 基亞生技 | |||
| 14:40~15:00 | 肝分子檢測的趨勢 | 林宗慶董事長 普生公司 | |||
| 15:00~15:20 | 分子檢測應用開發技術平台建立 | 陳奕雄總經理 賽亞基因科技 | |||
| 15:20~15:30 | Break |
| |||
| 15:30~15:50 | 國際分子檢測市場與趨勢 | 李聖婉總經理 華聯生技 | |||
| 15:50~16:10 | 分子檢測試劑從開發設計到法規驗證之路 | 陳亦聖總經理 世基生物醫學 | |||
| 16:10~16:30 | 分子檢測儀器開發的臺灣利基 | 詹益鑑副總經理 嘉原科技 | |||
| 16:30~17:00 | 綜合討論 | 李鍾熙董事長 生技中心 | |||
| 17:00~ | 活動結束 |
|